SGX welcomes The Trendlines Group as 100th new listing on Catalist
Trendlines creates, develops and invests in medical and agricultural technology companies, with the aim of eventual exit from these investments. It operates principally through its two subsidiaries - Trendlines Medical and Trendlines Agtech and its internal innovation centre, Trendlines Labs.
Todd Dollinger, Co-Chairman and CEO of Trendlines, said, “We are excited and honoured to be the 100th company to list on Catalist. We view Asia as a land of opportunities for incubation and commercialisation in the medtech and agritech sectors. Employing Trendlines’ expertise in establishing portfolio companies and developing them through investment and comprehensive support, we believe that we are well-positioned to partner with local inventors, entrepreneurs and multinational corporations.”
Steve Rhodes, Co-Chairman and CEO of Trendlines, added, “Trendlines’ listing on Catalist is expected to provide us a gateway to capital that will facilitate future investments, as well as an enhanced platform for business opportunities and strategic partnerships in Singapore and the region. We believe that Trendlines’ IPO is also in tune with the closer ties and several initiatives being fostered between the Singapore and Israeli governments. While the macro and policy environment is expected to become increasingly conducive for our business growth, we look forward to contributing our part in the cooperation between the two countries.”
Mohamed Nasser Ismail, Head of SME Development & Listings, SGX, said, “We are excited to welcome Trendlines to Catalist, and are pleased that they have chosen our platform to support their expansion plans into new markets. This is the first Israeli company listed on Catalist, and we look forward to supporting Trendlines’ growth in Israel and Asia.”
“Trendlines’ listing also represents a significant milestone for SGX, as we celebrate the 100th new listing on Catalist since it was launched eight years ago. Catalist is now an established platform for growth companies to raise capital. We will continue to build on its capability to support such companies to tap into the Singapore capital markets,” he added.
The listing of Trendlines brings the total number of Catalist companies on SGX to 170?, with a combined market capitalisation of S\\$10 billion. Its listing also brings the total amount of funds raised from new listings since the Catalist regime started to over S\\$1.4 billion. For further information on Catalist, please click here.
Trendlines opened at \\$0.34 today.
Комментарии